Protalix BioTherapeutics
PLX
$1.15
Share price
-2.54%
Change (1 day)
-58.63%
Change (1 year)
Categories
Protalix BioTherapeutics (PLX) - P/B ratio
P/B ratio as of April 2024 : 2.50
According to Protalix BioTherapeutics
's latest financial reports the company has a price-to-book ratio of 2.50.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Protalix BioTherapeutics - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.87 | -159.3% |
| 2022-12-31 | -6.52 | 3.93% |
| 2021-12-31 | -6.28 | 40.25% |
| 2020-12-31 | -4.48 | 546.71% |
| 2019-12-31 | -0.6921 | -20.69% |
| 2018-12-31 | -0.8727 | -72.18% |
| 2017-12-31 | -3.14 | -43.3% |
| 2016-12-31 | -5.53 | -159.09% |
| 2015-12-31 | 9.36 | -402.24% |
| 2014-12-31 | -3.10 | -77.05% |
| 2013-12-31 | -13.5 | -90.66% |
| 2012-12-31 | -145 | 792.89% |
| 2011-12-31 | -16.2 | -77.28% |
| 2010-12-31 | -71.3 | -311.47% |
| 2009-12-31 | 33.7 | 969.52% |
| 2008-12-31 | 3.15 | -22.12% |
| 2007-12-31 | 4.05 | -90.48% |
| 2006-12-31 | 42.5 | 944.99% |
| 2005-12-31 | 4.07 | 245.16% |
| 2004-12-31 | 1.18 | -33.79% |
| 2003-12-31 | 1.78 | 341.71% |
| 2002-12-31 | 0.4028 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.61 | -35.63% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | 6.13 | 144.87% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | 19.0 | 659.55% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.92 | -23.08% | 🇮🇱 Israel |